BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -31.93%932.2M | -52.92%304.14M | 79.29%1.54B | -4.27%1.24B | 24.24%1.37B | -47.27%646.02M | -51.90%859.14M | -26.72%1.3B | -11.01%1.1B | 41.43%1.23B |
Transactional financial assets | -86.80%748.56K | -2.25%730.35K | 618.80%5.66M | 1,140.72%10.63M | 545.57%5.67M | -98.55%747.14K | -99.04%786.97K | -99.50%856.6K | -99.51%878.26K | -68.71%51.63M |
Notes receivable and accounts receivable | 120.17%1.63B | 126.72%1.39B | 121.02%1.17B | 70.86%778.71M | 38.40%742.58M | -29.58%612.6M | -31.41%530.39M | -8.99%455.76M | -22.77%536.56M | 9.56%869.95M |
-Accounts receivable | 120.17%1.63B | 126.72%1.39B | 121.02%1.17B | 70.86%778.71M | 38.40%742.58M | -29.58%612.6M | -31.41%530.39M | -8.99%455.76M | -22.77%536.56M | 9.56%869.95M |
Other receivables (including interest and dividends) | 76.43%63.72M | 112.63%65.25M | 6.95%66.19M | -62.27%38.82M | -68.73%36.12M | -39.31%30.69M | 340.54%61.89M | 419.49%102.89M | 1,390.00%115.48M | 501.90%50.57M |
-Accrued interest receivable | ---- | ---- | 292.48%5.88M | --1.97M | ---- | --591.27K | 4.97%1.5M | ---- | ---- | ---- |
-Other receivable | ---- | ---- | ---- | -64.18%36.85M | ---- | -40.48%30.1M | ---- | 419.49%102.89M | ---- | 501.90%50.57M |
Advance payment | 34.39%100.33M | -3.38%75.29M | 6.37%105.66M | 3.82%109.02M | -64.95%74.66M | -55.74%77.92M | -71.45%99.33M | 54.82%105.01M | 172.05%213M | 216.91%176.06M |
Inventories | 42.17%637.02M | 41.90%603.43M | 24.99%537.41M | 38.60%620.06M | -5.30%448.08M | 6.64%425.26M | 10.58%429.96M | -4.10%447.37M | 33.66%473.15M | 59.33%398.79M |
Receivable financing | 5.05%207.27M | 4.82%150.78M | 181.09%215.82M | -41.85%182.72M | -46.84%197.31M | -50.87%143.84M | -75.27%76.78M | 126.15%314.2M | -47.20%371.16M | -51.75%292.77M |
Other current assets | 420.51%966.02M | 806.15%1.36B | 46.61%185.7M | 102.23%204.8M | 19.47%185.59M | 0.68%150.03M | 12.99%126.66M | 63.58%101.28M | 149.41%155.35M | 105.51%149.02M |
Total current assets | 48.47%4.54B | 89.01%3.95B | 75.25%3.83B | 12.82%3.19B | 3.06%3.06B | -35.01%2.09B | -42.72%2.18B | -11.66%2.82B | -10.57%2.97B | 14.02%3.21B |
Non Current assets | ||||||||||
Investment real estate | 202.74%61.68M | 202.09%62.61M | 196.61%62.52M | -6.57%20.02M | -6.54%20.37M | -6.44%20.73M | -6.34%21.08M | -6.24%21.43M | 6.28%21.8M | 37.72%22.15M |
Long-term equity investment | -0.24%33.78M | -0.36%33.8M | -0.20%33.89M | 0.15%33.97M | -0.14%33.86M | 0.07%33.93M | --33.96M | --33.92M | -63.57%33.91M | -63.39%33.91M |
Fixed assets | ---- | ---- | ---- | 16.13%2.46B | ---- | 29.91%2.39B | ---- | 58.53%2.12B | ---- | 102.24%1.84B |
Fixed assets liquidation | ---- | ---- | ---- | 828.75%2.16M | ---- | 143.05%2.16M | ---- | -73.83%232.67K | ---- | -33.69%889.1K |
Constru in process | ---- | ---- | ---- | 106.04%2.55B | ---- | 223.97%2.31B | ---- | 140.91%1.24B | ---- | 20.31%711.73M |
Construction materials | ---- | ---- | ---- | -21.02%13.2M | ---- | -28.38%13.29M | ---- | -12.18%16.72M | ---- | 57.28%18.56M |
Intangible assets | 16.06%368.2M | 16.52%371.68M | 12.11%358.9M | 12.12%361.84M | 9.68%317.26M | 17.76%318.99M | 38.12%320.13M | 119.86%322.71M | 144.16%289.27M | 180.08%270.88M |
Long deferred expense | -41.67%140.77K | -44.44%150.82K | 1,461.01%4.71M | 1,386.67%4.93M | -89.16%241.31K | -95.80%271.48K | -95.84%301.64K | -95.63%331.81K | -78.36%2.23M | 1,159.54%6.46M |
Deferred tax assets | 334.68%60.68M | 305.76%61.19M | 9.02%12.2M | 25.07%13.59M | 10.97%13.96M | -22.32%15.08M | 11.67%11.19M | 6.06%10.86M | 7.45%12.58M | 60.49%19.41M |
Usufruct assets | -1.05%7.14M | -5.43%7.22M | -4.68%7.57M | -5.25%7.93M | -17.90%7.22M | -17.18%7.63M | -17.57%7.94M | -6.72%8.37M | -4.92%8.79M | -3.21%9.21M |
Other non current assets | -74.65%18.85M | -75.26%20.37M | -78.71%28.28M | -86.66%35.47M | -81.74%74.35M | -68.45%82.33M | 10.20%132.82M | 5.26%265.95M | 143.44%407.07M | 100.92%260.96M |
Total non current assets | 7.22%5.68B | 9.90%5.7B | 19.53%5.59B | 36.30%5.5B | 45.57%5.3B | 62.53%5.19B | 84.57%4.68B | 74.04%4.03B | 80.02%3.64B | 70.61%3.19B |
Total assets | 22.32%10.22B | 32.61%9.65B | 37.26%9.42B | 26.63%8.68B | 26.47%8.36B | 13.59%7.28B | 8.11%6.87B | 24.36%6.86B | 23.71%6.61B | 36.59%6.41B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 223.98%996.02M | 173.67%1.01B | 143.91%840.34M | 87.76%747.79M | 12.32%307.43M | 219.91%367.89M | 189.52%344.52M | 721.18%398.27M | 4,876.66%273.72M | 5,650.00%115M |
Notes payable and accounts payable | 87.36%2.74B | 46.57%2.19B | 66.51%2.08B | 14.34%1.39B | 39.44%1.46B | 29.99%1.49B | 30.92%1.25B | 119.41%1.22B | 90.56%1.05B | 135.88%1.15B |
-Notes payable | 320.56%1.41B | 251.57%779.39M | 476.34%766.53M | -62.60%144.7M | -9.81%335.37M | -26.12%221.69M | -52.93%133M | 1,967.14%386.85M | 845.47%371.85M | 663.18%300.08M |
-Accounts payable | 17.83%1.33B | 10.85%1.41B | 17.67%1.31B | 50.15%1.25B | 66.56%1.12B | 49.82%1.27B | 66.22%1.12B | 54.94%831.07M | 32.36%675.29M | 89.59%849.2M |
Contract liabilities | -32.98%40.07M | -28.35%39.81M | -10.28%76.92M | -18.61%58.82M | -41.37%59.79M | -48.69%55.56M | -67.96%85.73M | -26.90%72.27M | 9.93%101.98M | 63.26%108.3M |
Salaries payable | -12.21%104.12M | -18.68%133.96M | -17.97%98.23M | -9.38%106.8M | -9.13%118.61M | -17.93%164.73M | -32.23%119.75M | -30.29%117.86M | -33.58%130.53M | -3.59%200.73M |
Taxs payable | 35.52%8.52M | -6.05%6.06M | 4.73%6.71M | -9.62%5.37M | -4.75%6.29M | -42.66%6.45M | -84.65%6.41M | -90.03%5.94M | -95.00%6.6M | -90.22%11.25M |
Other payable (including interest and dividends) | -11.90%63.07M | -4.35%62.54M | -5.76%60.21M | 19.41%68.3M | 26.75%71.59M | 14.15%65.38M | 8.67%63.89M | -17.70%57.2M | -19.77%56.48M | -27.46%57.27M |
-Other payable | ---- | ---- | ---- | 19.41%68.3M | ---- | 14.15%65.38M | ---- | -17.70%57.2M | ---- | -27.46%57.27M |
Non current liabilities due within one year | 99.54%255.77M | 162.61%259.41M | 319.98%234.44M | 308.07%236.21M | 137.04%128.18M | 75.33%98.78M | 1,759.06%55.82M | 83.05%57.88M | 1,786.46%54.08M | 3,549.39%56.34M |
Other current liabilities | 276.89%29.34M | 157.06%18.57M | 16.84%13.02M | -19.13%7.65M | -41.54%7.79M | -48.74%7.22M | -67.96%11.14M | -26.43%9.46M | 13.02%13.32M | 64.56%14.09M |
Total current liabilities | 95.97%4.23B | 64.46%3.72B | 76.09%3.41B | 35.15%2.62B | 28.05%2.16B | 31.65%2.26B | 16.95%1.94B | 85.73%1.94B | 58.91%1.69B | 77.36%1.72B |
Current liabilities | ||||||||||
Long term loan | -3.50%1.67B | 176.64%1.57B | 328.53%1.63B | 302.29%1.62B | 332.96%1.74B | 233.36%568.01M | 89.41%380.42M | 86.34%402.39M | 141.53%400.81M | 65.26%170.39M |
Estimate liabilities | -95.23%210K | -95.23%210K | 1,998.20%4.41M | 1,998.20%4.41M | 1,998.20%4.41M | 1,998.20%4.41M | -80.59%210K | -80.59%210K | -80.59%210K | -80.59%210K |
Deferred tax liabilities | -47.62%23.52M | -48.41%23.37M | -15.65%44.87M | -14.18%44.89M | -14.18%44.9M | -13.41%45.31M | 15.45%53.2M | 57.38%52.31M | 62.28%52.32M | 97.02%52.32M |
Long term deferred income | -8.44%5.46M | -7.71%5.64M | -10.98%5.57M | -8.27%5.79M | 106.11%5.96M | 100.50%6.11M | 92.43%6.26M | 108.48%6.31M | -12.20%2.89M | -14.44%3.05M |
Lease liabilities | -4.70%6.6M | 14.50%7.85M | -1.58%8.17M | -1.39%8.09M | -14.54%6.93M | -32.06%6.86M | -18.29%8.3M | -3.49%8.2M | -3.53%8.11M | 3.74%10.1M |
Total non current liabilities | -4.84%1.71B | 155.03%1.61B | 277.63%1.69B | 258.30%1.68B | 287.12%1.8B | 167.17%630.69M | 71.53%448.38M | 79.31%469.43M | 120.10%464.34M | 63.89%236.06M |
Total liabilities | 50.18%5.94B | 84.22%5.33B | 113.99%5.1B | 78.61%4.31B | 83.98%3.96B | 48.03%2.89B | 24.40%2.38B | 84.45%2.41B | 69.06%2.15B | 75.62%1.95B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M | 0.00%202.68M |
Capital reserve funds | -0.89%423.96M | -1.57%420.01M | -0.57%429.86M | -0.24%428.81M | -1.70%427.75M | -0.82%426.7M | 1.66%432.35M | 2.24%429.82M | 3.92%435.16M | 2.74%430.25M |
Surplus reserve funds | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M | 0.00%143.66M |
Retained profit | -1.54%3.07B | 0.27%3.1B | -1.53%3.09B | 0.95%3.12B | -0.71%3.12B | -1.34%3.09B | 1.22%3.14B | 6.84%3.09B | 14.08%3.14B | 36.03%3.13B |
Specific reserves | 19.41%36.53M | 14.75%30.35M | 9.64%28.85M | 27.91%28.79M | 5.25%30.59M | -14.77%26.45M | -44.17%26.31M | -50.30%22.51M | -31.49%29.07M | -13.71%31.03M |
Shareholders equity without minority interests | -1.17%3.88B | 0.14%3.9B | -1.22%3.9B | 0.89%3.92B | -0.71%3.92B | -1.27%3.89B | 0.62%3.95B | 4.98%3.89B | 10.97%3.95B | 26.94%3.94B |
Minority interests | -15.80%399.44M | -13.56%427.84M | -20.93%421.76M | -18.60%452.94M | -5.84%474.41M | -3.37%494.97M | 4.57%533.42M | 10.96%556.47M | -0.60%503.81M | 8.23%512.23M |
Total shareholder equity | -2.75%4.28B | -1.40%4.32B | -3.57%4.32B | -1.55%4.38B | -1.29%4.4B | -1.52%4.39B | 1.07%4.48B | 5.70%4.45B | 9.53%4.46B | 24.47%4.45B |
Total liabilityies and equity | 22.32%10.22B | 32.61%9.65B | 37.26%9.42B | 26.63%8.68B | 26.47%8.36B | 13.59%7.28B | 8.11%6.87B | 24.36%6.86B | 23.71%6.61B | 36.59%6.41B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.